Leukaemia
Leukaemia is cancer which starts in blood-forming tissue, usually the bone marrow. It leads to the over-production of abnormal white blood cells, the part of the immune system which defends the body against infection, but some leukemias start in other blood cell types. There are several types of Leukaemia, which are divided based mainly on whether the leukaemia is acute (fast-growing) or chronic (slower growing), and whether it starts in myeloid cells or lymphoid cells. Different types of leukaemia have different treatment options and outlooks.
Acute Lymphocytic (or lymphoblastic) Leukaemia (ALL) is a cancer of the lymphocytes. It is more common in children than in adults
Acute Myeloid Leukaemia (AML) is also called Acute Myelocytic Leukaemia, Acute Myelogenous Leukaemia, Acute Granulocytic Leukaemia, Acute Non-Lymphocytic Leukaemia
Chronic Lymphocytic Leukaemia (CLL) mainly affects older adults and accounts for about one-third of all Leukaemia.
Chronic Myeloid Leukaemia (CML) also known as Chronic Myelogenous Leukaemia. It’s a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood.
Chronic Myelomonocytic Leukaemia (CMML) People with CMML may have shortages of some blood cells, but the main problem is too many monocytes.
Leukaemia in Children is the most common cancer in children and teens, accounting for almost 1 out of 3 cancers. Most childhood Leukaemia is Acute Lymphocytic Leukaemia (ALL). Most of the remaining cases are Acute Myeloid Leukaemia(AML)
Treatment of Blood Cancer
- Intensive chemotherapy: Can be divided into 3 phases: Induction, Post-remission, and Consolidation or stem cell transplantation.
- Targeted therapy
- Radiation therapy
-
GLIVEC (Imatinib Mesylate)
₹1.00 – ₹2.00 -
IMASAB (Imatinib Mesylate)
₹1.00 – ₹2.00 -
IMBRUVICA (Ibrutinib)-140 mg
-
LENASAB (Lenalidomide)
₹1.00 – ₹2.00 -
PEG L- ASPATERO (PEG L-Asparaginase)-5ml
-
RISTOVA (Rituximab)
₹1.00 – ₹2.00 -
SPRYCEL (Dasatinib)- 50mg
-
TAURITMO (Midostaurin)-25mg